Effect of betaxolol on the hemodynamic, gas exchange, and cardiac output response to exercise in chronic atrial fibrillation

Chest

Volumn 115, Issue 4, 1999, Pages 1175-1180

  Atwood, J Edwin ^a,b   Myers, Jonathan ^a   Quaglietti, Susan ^a   Grumet, Jill ^a   Gianrossi, Renato ^a   Umman, Tianna ^a  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Atrial fibrillation; Beta blockade; Exercise capacity; Oxygen uptake

Indexed keywords

BETAXOLOL; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; EXERCISE; GAS EXCHANGE; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032932332     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.4.1175     Document Type: Article

References (25)

1. 1 Atwood JE, Myers J. Exercise hemodynamics of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial fibrillation: mechanisms and Management, 2nd ed. Philadelphia: Lippincott-Raven, 1997; 219-240
2. 2 Falk RH. Antithrombotic therapy in atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial fibrillation: mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997; 277-298
3. 3 Yahalom J, Klein H, Kaplinsky E. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. Chest 1977; 71:582-592
4. 4 Atwood JE, Sullivan M, Forbes S, et al. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol 1987; 10:314-320
5. 5 Molajo AO, Coupe MO, Bennett DH. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. Br Heart J 1984; 52:392-395
6. 6 Wong CK, Lau CP, Leung WH, et al. Usefulness of labetalol in chronic atrial fibrillation. Am J Cardiol 1990; 66:1212-1215
7. 7 DiBianco R, Morganroth J, Freitag JA, et al. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. Am Heart J 1984; 108:1121-1127
8. 8 Koh KK, Kwon KS, Park HB, et al. Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation. Am J Cardiol 1995; 75:88-90
9. 9 Zoble RG, Brewington J, Olukotun AY, et al. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation. Am J Cardiol 1987; 60:39D-45D
10. 10 Christ M, Rauen P, Klauss V, et al. Spontaneous changes of heart rate, blood pressure, and ischemia-type-ST segment depressions in patients with hypertension without significant coronary artery disease: beneficial effects of beta-blockade. J Cardiovasc Pharmacol 1996; 28:755-763
11. 11 Alpert MA, Mukerji V, Villarreal D, et al. Efficacy of betaxolol in the treatment of stable exertional angina pectoris: a dose-ranging study. Angiology 1990; 41:365-376
12. 12 Myers J, Buchanan N, Walsh D, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991; 17:1334-1342
13. 13 Atwood JE, Myers J, Sandhu S, et al. Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. Am J Cardiol 1989; 69:45-48
14. 14 Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2:92-98
15. 15 Myers J, Walsh D, Sullivan M, et al. Effect of sampling on variability and plateau in oxygen uptake. J Appl Physiol 1990; 68:404-410
16. 16 Shimizu M, Myers J, Buchanan N, et al. The ventilatory threshold: method, protocol, and evaluator agreement. Am Heart J 1991; 122:509-516
17. 2 rise during rebreathing. J Appl Physiol 1958; 13:159-164
18. 18 Myers J. Essentials of cardiopulmonary exercsie testing. Champaign, IL: Human Kinetics, 1996
19. 19 Goldman S, Probst P, Selzer A, et al. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol 1975; 35:651-655
20. 20 David D, DiSegni E, Klein HO, et al. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added β-adrenergic blocking agent. Am J Cardiol 1978; 44:1378-1382
21. 21 Wilmore JH. Exercise testing, training, and beta-adrenergic blockade. Physician Sports Med 1988; 16:45-52
22. 22 Atwood JE, Myers J, Sullivan M, et al. Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol 1988; 11:508-513
23. 23 Ueshima K, Myers J, Ribisl PM, et al. Hemodynamic determinants of exercise capacity in chronic atrial fibrillation. Am Heart J 1993; 125:1301-1305
24. 2 rebreathing method for measuring cardiac output in patients with hypertension or heart failure. J Lab Clin Med 1976; 88:672-682
25. 25 Myers J, Atwood JE, Sullivan M, et al. Perceived exertion and gas exchange after calcium and β-blockade in atrial fibrillation. J Appl Physiol 1987; 63:97-104